Cargando…

PKCβ Facilitates Leukemogenesis in Chronic Lymphocytic Leukaemia by Promoting Constitutive BCR-Mediated Signalling

SIMPLE SUMMARY: Chronic lymphocytic leukaemia (CLL) is the most common blood cancer in the Western world and remains incurable. While a cause for this cancer has not been defined, one specific protein, protein kinase CβII (PKCβII), is highly expressed in CLL cells and is linked with a poorer clinica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hay, Jodie, Tarafdar, Anuradha, Holroyd, Ailsa K., Moka, Hothri A., Dunn, Karen M., Alshayeb, Alzahra, Lloyd, Bryony H., Cassels, Jennifer, Malik, Natasha, Khan, Ashfia F., Sou, IengFong, Lees, Jamie, Almuhanna, Hassan N. B., Kalakonda, Nagesh, Slupsky, Joseph R., Michie, Alison M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9735720/ https://www.ncbi.nlm.nih.gov/pubmed/36497487 http://dx.doi.org/10.3390/cancers14236006

Ejemplares similares

Effect of Ras Inhibition in Hematopoiesis and BCR/ABL Leukemogenesis
por: Baum, Karina J, et al.
Publicado: (2008)

Targeting the SH2-Kinase Interface in Bcr-Abl Inhibits Leukemogenesis
por: Grebien, Florian, et al.
Publicado: (2011)

A novel transgenic mouse strain expressing PKCβII demonstrates expansion of B1 and marginal zone B cell populations
por: Azar, Ali A., et al.
Publicado: (2020)

Autophagy is Essential to Suppress Cell Stress and to Allow BCR-Abl-Mediated Leukemogenesis
por: Altman, Brian J., et al.
Publicado: (2010)

PAK-dependent STAT5 serine phosphorylation is required for BCR-ABL-induced leukemogenesis
por: Berger, A, et al.
Publicado: (2014)

CLL Exosomes Modulate the Transcriptome and Behaviour of Recipient Stromal Cells and Are Selectively Enriched in miR-202-3p
por: Farahani, Mosavar, et al.
Publicado: (2015)

BCR-ABL triggers a glucose-dependent survival program during leukemogenesis through the suppression of TXNIP
por: Feng, Lin, et al.
Publicado: (2023)

Phosphorylation of SOS1 on tyrosine 1196 promotes its RAC GEF activity and contributes to BCR-ABL leukemogenesis
por: Gerboth, S, et al.
Publicado: (2018)

The phosphatase UBASH3B/Sts-1 is a negative regulator of Bcr-Abl kinase activity and leukemogenesis
por: Mian, Afsar A., et al.
Publicado: (2019)

Kinobead Profiling Reveals Reprogramming of BCR Signaling in Response to Therapy within Primary CLL Cells
por: Linley, Adam J., et al.
Publicado: (2021)

Monoubiquitinated Fanconi Anemia D2 (FANCD2-Ub) Is Required for BCR-ABL1 Kinase -Induced Leukemogenesis
por: Koptyra, Mateusz, et al.
Publicado: (2011)

c-Myb and its target Bmi1 are required for p190BCR/ABL leukemogenesis in mouse and human cells
por: Waldron, Todd, et al.
Publicado: (2011)

Signal Transducer and Activator of Transcription (STAT)5 Activation by BCR/ABL Is Dependent on Intact Src Homology (SH)3 and SH2 Domains of BCR/ABL and Is Required for Leukemogenesis
por: Nieborowska-Skorska, Malgorzata, et al.
Publicado: (1999)

The process of leukemogenesis.
por: Irons, R D, et al.
Publicado: (1996)

A screen for Fli-1 transcriptional modulators identifies PKC agonists that induce erythroid to megakaryocytic differentiation and suppress leukemogenesis
por: Liu, Tangjingjun, et al.
Publicado: (2016)

Abi1 gene silencing by short hairpin RNA impairs Bcr-Abl-induced cell adhesion and migration in vitro and leukemogenesis in vivo
por: Yu, Weidong, et al.
Publicado: (2008)

Low Expression of miR-196b Enhances the Expression of BCR-ABL1 and HOXA9 Oncogenes in Chronic Myeloid Leukemogenesis
por: Liu, Yue, et al.
Publicado: (2013)

The Philadelphia chromosome in leukemogenesis
por: Kang, Zhi-Jie, et al.
Publicado: (2016)

mTORC1-selective activation of translation elongation promotes disease progression in chronic lymphocytic leukemia
por: Malik, Natasha, et al.
Publicado: (2023)

Creation of Philadelphia chromosome by CRISPR/Cas9-mediated double cleavages on BCR and ABL1 genes as a model for initial event in leukemogenesis
por: Tamai, Minori, et al.
Publicado: (2022)

Leukemogenesis and ageing: ‘fit for transformation’ ?
por: Greaves, Mel
Publicado: (2011)

P62(dok), a Negative Regulator of Ras and Mitogen-Activated Protein Kinase (Mapk) Activity, Opposes Leukemogenesis by P210(bcr-abl)
por: Di Cristofano, Antonio, et al.
Publicado: (2001)

PKCβ regulates BCR-mediated IKK activation by facilitating the interaction between TAK1 and CARMA1
por: Shinohara, Hisaaki, et al.
Publicado: (2005)

Granulocyte colony-stimulating factor and leukemogenesis.
por: de Figueiredo, Lorena Lobo, et al.
Publicado: (2004)

Mesenchymal niche: the sensor and effector of leukemogenesis
por: Oh, Il-Hoan
Publicado: (2015)

The Role of TAL1 in Hematopoiesis and Leukemogenesis
por: Vagapova, E. R., et al.
Publicado: (2018)

A Prospective Analysis of Human Leukemogenesis
por: Eaves, Connie J.
Publicado: (2018)

NSD1 in erythroid differentiation and leukemogenesis
por: Tauchmann, Samantha, et al.
Publicado: (2020)

Editorial: Mechanisms of Epigenetics and Genetics in Leukemogenesis
por: Li, Yonghui, et al.
Publicado: (2022)

Trib2 expression in granulocyte-monocyte progenitors drives a highly drug resistant acute myeloid leukaemia linked to elevated Bcl2
por: O’Connor, Caitriona, et al.
Publicado: (2018)

Deregulated hedgehog pathway signaling is inhibited by the smoothened antagonist LDE225 (Sonidegib) in chronic phase chronic myeloid leukaemia
por: Irvine, David A., et al.
Publicado: (2016)

CRISPR/CAS9-mediated knockout of Abi1 inhibits p185(Bcr-Abl)-induced leukemogenesis and signal transduction to ERK and PI3K/Akt pathways
por: Faulkner, James, et al.
Publicado: (2020)

Protein kinase C in cellular transformation: a valid target for therapy?
por: Tarafdar, Anuradha, et al.
Publicado: (2014)

Molecular and Epigenetic Mechanisms of MLL in Human Leukemogenesis
por: Ballabio, Erica, et al.
Publicado: (2012)

Osteogenic niche in the regulation of normal hematopoiesis and leukemogenesis
por: Le, Phuong M., et al.
Publicado: (2018)

RAF Kinase Inhibitor Protein in Myeloid Leukemogenesis
por: Zebisch, Armin, et al.
Publicado: (2019)

CD93 is expressed on chronic myeloid leukemia stem cells and identifies a quiescent population which persists after tyrosine kinase inhibitor therapy
por: Kinstrie, Ross, et al.
Publicado: (2020)

Correction: CD93 is expressed on chronic myeloid leukemia stem cells and identifies a quiescent population which persists after tyrosine kinase inhibitor therapy
por: Kinstrie, Ross, et al.
Publicado: (2020)

Transcriptional mechanism of vascular endothelial growth factor-induced expression of protein kinase CβII in chronic lymphocytic leukaemia cells
por: Al-Sanabra, Ola, et al.
Publicado: (2017)

Aging-Associated Changes in Hematopoiesis and Leukemogenesis: What's the Connection?
por: Henry, Curtis J., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_1et9ihefe88oijdfdpk3gmnki7